US Patent Family Members and Approved Drugs for United States of America Patent: 2022088196
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: US2022088196
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2025-12-16 | blinatumomab | Amgen, Inc. | BLINCYTO |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
